Novel loci interacting epistatically with bone morphogenetic protein receptor 2 cause familial pulmonary arterial hypertension

Journal of Heart and Lung Transplantation

Volumn 29, Issue 2, 2010, Pages 174-180

  Rodriguez Murillo, Laura ^a   Subaran, Ryan ^a   Stewart, William C L ^a   Pramanik, Sreemanta ^a   Marathe, Sudhir ^a   Barst, Robyn J ^a   Chung, Wendy K ^a   Greenberg, David A ^a  

^a Department of Medicine   (United States)

Author keywords

BMPR2; gene gene interaction; genome scan; linkage analysis

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 2;

ARTICLE; BMPR2 GENE; CHROMOSOME 13Q; CHROMOSOME 2P; CHROMOSOME 3P; CHROMOSOME 3Q; CLINICAL ARTICLE; FAMILIAL DISEASE; GENE; GENE INTERACTION; GENE LOCUS; GENE MUTATION; GENETIC EPISTASIS; HUMAN; PENETRANCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SINGLE NUCLEOTIDE POLYMORPHISM;

BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; GENETIC LOCI; GENOTYPE; HUMANS; HYPERTENSION, PULMONARY; PEDIGREE; RISK FACTORS;

EID: 74849100584     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.08.022     Document Type: Article

References (45)

1. Proceedings of the 4th World Symposium on Pulmonary Hypertension, February 2008, Dana Point, California, USA. J Am Coll Cardiol 54 (2009) S1-S117
2. Sztrymf B., Coulet F., Girerd B., et al. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Am J Respir Crit Care Med 177 (2008) 1377-1383
3. Morse J.H., Jones A.C., Barst R.J., Hodge S.E., Wilhelmsen K.C., and Nygaard T.G. Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-q32. Circulation 95 (1997) 2603-2606
4. Lane K.B., Machado R.D., Pauciulo M.W., et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 26 (2000) 81-84
5. Deng Z., Haghighi F., Helleby L., et al. Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33. Am J Respir Crit Care Med 161 (2000) 1055-1059
6. Thomson J.R., Machado R.D., Pauciulo M.W., et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 37 (2000) 741-745
7. Machado R.D., Pauciulo M.W., Thomson J.R., et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 68 (2001) 92-102
8. Machado R.D., Aldred M.A., James V., et al. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat 27 (2006) 121-132
9. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1 (2000) 169-178
10. Chen D., Zhao M., and Mundy G.R. Bone morphogenetic proteins. Growth Factors 22 (2004) 233-241
11. Liu F., Ventura F., Doody J., and Massague J. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 15 (1995) 3479-3486
12. Newman J.H., Phillips III J.A., and Loyd J.E. Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies. Ann Intern Med 148 (2008) 278-283
13. Morrell N.W., Yang X., Upton P.D., et al. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. Circulation 104 (2001) 790-795
14. Mandegar M., Fung Y.C., Huang W., Remillard C.V., Rubin L.J., and Yuan J.X. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res 68 (2004) 75-103
15. Davies R.J., and Morrell N.W. Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor. Chest 134 (2008) 1271-1277
16. Tada Y., Majka S., Carr M., et al. Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH. Am J Physiol Lung Cell Mol Physiol 292 (2007) L1556-L1563
17. Hong K.H., Lee Y.J., Lee E., et al. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension. Circulation 118 (2008) 722-730
18. Said S.I. Mediators and modulators of pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 291 (2006) L547-L558
19. Huang Q., Shete S., and Amos C.I. Ignoring linkage disequilibrium among tightly linked markers induces false-positive evidence of linkage for affected sib pair analysis. Am J Hum Genet 75 (2004) 1106-1112
20. Boyles A.L., Scott W.K., Martin E.R., et al. Linkage disequilibrium inflates type I error rates in multipoint linkage analysis when parental genotypes are missing. Hum Hered 59 (2005) 220-227
21. Li B., and Leal S.M. Ignoring intermarker linkage disequilibrium induces false-positive evidence of linkage for consanguineous pedigrees when genotype data is missing for any pedigree member. Hum Hered 65 (2008) 199-208
22. Nathanson K.L., Shugart Y.Y., Omaruddin R., et al. CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q. Hum Mol Genet 11 (2002) 1327-1332
23. Kim S.H., Ma X., Klupa T., et al. Genetic modifiers of the age at diagnosis of diabetes (MODY3) in carriers of hepatocyte nuclear factor-1alpha mutations map to chromosomes 5p15, 9q22, and 14q24. Diabetes 52 (2003) 2182-2186
24. Gayan J., Brocklebank D., Andresen J.M., et al. Genomewide linkage scan reveals novel loci modifying age of onset of Huntington's disease in the Venezuelan HD kindreds. Genet Epidemiol 32 (2008) 445-453
25. Kruglyak L., Daly M.J., Reeve-Daly M.P., and Lander E.S. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 58 (1996) 1347-1363
26. Kruglyak L., and Lander E.S. Faster multipoint linkage analysis using Fourier transforms. J Comput Biol 5 (1998) 1-7
27. Hodge S.E., Abreu P.C., and Greenberg D.A. Magnitude of type I error when single-locus linkage analysis is maximized over models: a simulation study. Am J Hum Genet 60 (1997) 217-227
28. Pal D.K., Durner M., and Greenberg D.A. Effect of misspecification of gene frequency on the two-point LOD score. Eur J Hum Genet 9 (2001) 855-859
29. Greenberg D.A., Abreu P., and Hodge S.E. The power to detect linkage in complex disease by means of simple LOD-score analyses. Am J Hum Genet 63 (1998) 870-879
30. Greenberg D.A., and Abreu P.C. Determining trait locus position from multipoint analysis: accuracy and power of three different statistics. Genet Epidemiol 21 (2001) 299-314
31. Bacanu S.A. Multipoint linkage analysis for a very dense set of markers. Genet Epidemiol 29 (2005) 195-203
32. Efron BaT, R. J. An Introduction to the Bootstrap. Chapman & Hall, New York 1993.
33. Stewart W.C. Improving estimates of genetic maps: a meta-analysis-based approach. Genet Epidemiol 31 (2007) 408-416
34. Dipple K.M., and McCabe E.R. Modifier genes convert "simple" Mendelian disorders to complex traits. Mol Genet Metab 71 (2000) 43-50
35. Daw E.W., Chen S.N., Czernuszewicz G., et al. Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy. Hum Mol Genet 16 (2007) 2463-2471
36. Daw E.W., Lu Y., Marian A.J., and Shete S. Identifying modifier loci in existing genome scan data. Ann Hum Genet 72 (2008) 670-675
37. Chenevix-Trench G., Milne R.L., Antoniou A.C., Couch F.J., Easton D.F., and Goldgar D.E. An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 9 (2007) 104
38. Ripperger T., Gadzicki D., Meindl A., and Schlegelberger B. Breast cancer susceptibility: current knowledge and implications for genetic counselling. Eur J Hum Genet 17 (2008) 722-731
39. Marcos E., Fadel E., Sanchez O., et al. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res 94 (2004) 1263-1270
40. Long L., MacLean M.R., Jeffery T.K., et al. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res 98 (2006) 818-827
41. Phillips III J.A., Poling J.S., Phillips C.A., et al. Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension. Genet Med 10 (2008) 359-365
42. Sehgal P.B., and Mukhopadhyay S. Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs?. Am J Physiol Heart Circ Physiol 293 (2007) H77-H85
43. Young K.A., Ivester C., West J., Carr M., and Rodman D.M. BMP signaling controls PASMC KV channel expression in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 290 (2006) L841-L848
44. Burg E.D., Remillard C.V., and Yuan J.X. Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications. Br J Pharmacol 153 suppl 1 (2008) S99-S111
45. West J., Cogan J., Geraci M., et al. Gene expression in BMPR2 mutation carriers with and without evidence of Pulmonary Arterial Hypertension suggests pathways relevant to disease penetrance. BMC Med Genomics 1 (2008) 45